«Often it is impossible to visually distinguish cancer from normal brain, so
invasive brain cancer cells frequently remain after surgery, leading to cancer recurrence and a worse prognosis,» says Dr. Kevin Petrecca, Chief of Neurosurgery and brain cancer researcher at The Neuro, and co-senior author of the study published today in Science Translational Medicine.
Comparative oncology research includes work in
invasive urinary bladder
cancer (transitional
cell carcinoma), lymphoma, and
brain cancer.